Medical Condition News

RSS

People with disabilities more likely to experience poorer health

Compared to racial and ethnic minority groups, people with disabilities are generally more likely to experience poorer health, according to a new report from the University of New Hampshire's Institute on Disability.

26 Aug 2011

Zinc may act as tumor suppressor in commonist form of pancreatic cancer

The essential element zinc has been shown in a new study to be a likely tumor suppressor in the commonist form of pancreatic cancer, University of Maryland scientists report in the current issue of the journal Cancer Biology & Therapy.

26 Aug 2011

Early-morning cigarette smokers more likely to develop lung, head and neck cancers

Two new studies have found that smokers who tend to take their first cigarette soon after they wake up in the morning may have a higher risk of developing lung and head and neck cancers than smokers who refrain from lighting up right away.

26 Aug 2011

Researchers reveal new gene associated with osteoarthritis

Researchers have today revealed a new gene associated with osteoarthritis. This is only the third gene to be identified for this painful and debilitating disease that affects more than 40 per cent of people aged more than 70 years.

26 Aug 2011

IOM issues new report on evidence and causality of vaccine harms

The Institute of Medicine's Panel on Adverse Effects of Vaccines issued a report today on the evidence and causality of vaccine harms. Despite a glowing press release, the report does little to allay public concerns over adverse effects of vaccines and suggests that we urgently need more science on vaccine adverse effects.

26 Aug 2011

Longer looks: Who is influencing health care?; Planned Parenthood's battle in the states; Oregon's new experiment

Right-wing radio host Rush Limbaugh once vowed to flee to Costa Rica if President Barack Obama's health care reforms took effect. Limbaugh might have overlooked a couple of critical details: Costa Rica's respected universal healthcare system is highly socialized. It's also on the verge of going broke. ... Costa Rica's broad coverage ranked better than most of the Americas, including the United States, in a 2000 World Health Organization index.

26 Aug 2011

Firazyr receives FDA approval for treatment of HAE acute attacks

The U.S. Food and Drug Administration today approved Firazyr (icatibant) Injection for the treatment of acute attacks of a rare condition called hereditary angioedema (HAE) in people ages 18 years and older.

26 Aug 2011

GCC hormone receptor may also help fight obesity

The hormone receptor guanylyl cyclase C (GCC) has been established as a suppressor of colorectal cancer tumors, but new evidence from Thomas Jefferson University suggests it may also help fight one of the country's biggest pandemics: obesity.

26 Aug 2011

FDA approves Avita's IDE for use of ReCell to treat hypertrophic dyspigmented scars

Avita Medical Ltd., the regenerative medicine company, today announced that the United States Food and Drug Administration (FDA) has approved the Company's investigational device exemption (IDE) feasibility study for the use of ReCell Spray-On-Skin in the treatment of hypertrophic dyspigmented scars: i.e., raised and/or discoloured scars.

26 Aug 2011

Omega-3s decreases severity of brain damage after stroke

A diet rich in omega-3s reduces the severity of brain damage after a stroke, according to a study conducted by Universit- Laval researchers. The team, co-directed by professors Jasna Kriz and Fr-d-ric Calon, showed that the extent of brain damage following a stroke was reduced by 25% in mice that consumed DHA type omega-3s daily.

26 Aug 2011

DaTscan allows doctors to differentiate Parkinson's from other movement disorders

Thanks to a new diagnostic imaging technique, physicians now have an objective test to evaluate patients for parkinsonian syndromes, such as Parkinson's disease. Northwestern Memorial Hospital is among the first institutions in the country to offer DaTscan-, the only FDA-approved imaging agent for assessment of movement disorders.

26 Aug 2011

Boehringer Ingelheim, Lilly receive EU approval for linagliptin to treat type 2 diabetes

Boehringer Ingelheim and Eli Lilly and Company today received Marketing Authorization from the European Commission for linagliptin 5 mg film-coated tablets for the treatment of adults with type 2 diabetes.

26 Aug 2011

Shire receives FDA marketing approval for FIRAZYR to treat acute attacks of HAE

Shire plc, the global specialty biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has granted marketing approval for FIRAZYR for treatment of acute attacks of hereditary angioedema (HAE) in adults 18 years of age and older.

26 Aug 2011

Allergan gets FDA nod for use of Botox in urinary incontinence

Allergan Inc. has received United States Food and Drug Administration (FDA) approval to market the wrinkle smoother Botox as a treatment for urinary incontinence. The FDA approved the drug for people with overactive bladders who have neurologic conditions such as multiple sclerosis and spinal cord injuries, the agency said today in a statement. The medicine is injected into the bladder to increase its capacity by relaxing muscles.

25 Aug 2011

Simcere receives Chinese SFDA approval for Iremod to treat active rheumatoid arthritis

Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today announced that it has received the new drug approval from the State Food and Drug Administration for Iremod.

25 Aug 2011

CVRx introduces CE Mark approved Barostim neo for treatment of uncontrolled hypertension

CVRx, Inc., a private medical device company, introduced today its second-generation implantable device, the Barostim neo, for the treatment of uncontrolled hypertension. The Barostim neo features a new unilateral, 1mm electrode and a new smaller, more advanced stimulator to allow for more focused and efficient delivery of therapy. These improvements have led to shorter procedure times and extended longevity.

25 Aug 2011

Researchers pave the way for functional analysis of non-protein-coding genes

When investigating cancer cells, researchers discovered numerous peculiarities: Particular RNA molecules are present in large numbers, particular genes are overactive. Do these characteristics have a relation to cancer? Do they promote cell growth? Do they inactivate growth brakes or are they just a whim of nature?

25 Aug 2011

Insight into how bacterial toxins cause human diseases may help improve treatment

A better understanding of how bacterial toxins cause common human diseases may lead to their improved treatment and prevention according to a paper just published by Irish and US scientists in Nature Reviews Microbiology.

25 Aug 2011

Study reveals striking brain similarities in bipolar disorder and schizophrenia

Researchers from the Royal College of Surgeons in Ireland (RCSI) and Beaumont Hospital have conducted a study which has found striking brain similarities in bipolar disorder and schizophrenia. The research has also pinpointed for the first time that a process which controls how information is transmitted from neuron to neuron in the brain is altered in both conditions and may potentially contribute to the developments of improved treatments in the future.

25 Aug 2011

Kinexus launches TranscriptoNET KnowledgeBase for human gene expression study

Kinexus Bioinformatics Corporation, a world-leader in molecular intelligence research, announced the launch of its TranscriptoNET KnowledgeBase for the study of human gene expression in over 300 types of human tissues and organs as well as over 300 human cancer cell lines.

25 Aug 2011

Medical Condition News

People with disabilities more likely to experience poorer health

Zinc may act as tumor suppressor in commonist form of pancreatic cancer

Early-morning cigarette smokers more likely to develop lung, head and neck cancers

Researchers reveal new gene associated with osteoarthritis

IOM issues new report on evidence and causality of vaccine harms

Longer looks: Who is influencing health care?; Planned Parenthood's battle in the states; Oregon's new experiment

Firazyr receives FDA approval for treatment of HAE acute attacks

GCC hormone receptor may also help fight obesity

FDA approves Avita's IDE for use of ReCell to treat hypertrophic dyspigmented scars

Omega-3s decreases severity of brain damage after stroke

DaTscan allows doctors to differentiate Parkinson's from other movement disorders

Boehringer Ingelheim, Lilly receive EU approval for linagliptin to treat type 2 diabetes

Shire receives FDA marketing approval for FIRAZYR to treat acute attacks of HAE

Allergan gets FDA nod for use of Botox in urinary incontinence

Simcere receives Chinese SFDA approval for Iremod to treat active rheumatoid arthritis

CVRx introduces CE Mark approved Barostim neo for treatment of uncontrolled hypertension

Researchers pave the way for functional analysis of non-protein-coding genes

Insight into how bacterial toxins cause human diseases may help improve treatment

Study reveals striking brain similarities in bipolar disorder and schizophrenia

Kinexus launches TranscriptoNET KnowledgeBase for human gene expression study

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News